Acessibilidade / Reportar erro

Treatment of mesenteric angina in patients with Takayasu's arteritis

Abstracts

Takayasu's arteritis (TA) is an idiopathic chronic inflammatory disease of the connective tissue that affects mainly the aorta and its branches. Treatment is mainly based on corticosteroids and immunosuppressants. We report the case of a 33-year-old female complaining of malaise, fever, myalgia, severe pulsing holocranial headache resistant to analgesics, systemic arterial hypertension hard to control, right lower limb claudication, and severe abdominal pain that worsened after the meals. Angiotomography revealed aneurysm of the ascending aorta, and stenosis of the following vessels: right common iliac artery, renal arteries, and superior mesenteric artery. Those findings supported the diagnosis of mesenteric angina and the interventional approach by use of percutaneous transluminal angioplasty with stent placement.

Takayasu's arteritis; percutaneous transluminal angioplasty; abdominal pain


Aarterite de Takayasu (AT) é uma doença inflamatória crônica do tecido conectivo, idiopática, que acomete preferencialmente a aorta e seus ramos. A terapêutica utilizada baseia-se sobretudo no uso de corticosteroides e imunossupressores. É relatado o caso de uma paciente, 33 anos, com mal-estar, febre, mialgia, cefaleia intensa, pulsátil, holocraniana, resistente a analgésicos, hipertensão arterial sistêmica de difícil controle, claudicação no membro inferior direito e dor abdominal de forte intensidade, a qual piorava após a alimentação. A angiotomografia revelou aneurisma da aorta ascendente, estenose da artéria ilíaca comum direita, estenose das artérias renais e estenose da artéria mesentérica superior, fato que embasou o diagnóstico de angina mesentérica e a conduta intervencionista através da angioplastia transluminal percutânea múltipla com a colocação de stents.

arterite de Takayasu; angioplastia transluminal percutânea; dor abdominal


CASE REPORT

IMedical student at the UFAL

IIRheumatologist of the UFAL

Correspondence to

ABSTRACT

Takayasu's arteritis (TA) is an idiopathic chronic inflammatory disease of the connective tissue that affects mainly the aorta and its branches. Treatment is mainly based on corticosteroids and immunosuppressants. We report the case of a 33-year-old female complaining of malaise, fever, myalgia, severe pulsing holocranial headache resistant to analgesics, systemic arterial hypertension hard to control, right lower limb claudication, and severe abdominal pain that worsened after the meals. Angiotomography revealed aneurysm of the ascending aorta, and stenosis of the following vessels: right common iliac artery, renal arteries, and superior mesenteric artery. Those findings supported the diagnosis of mesenteric angina and the interventional approach by use of percutaneous transluminal angioplasty with stent placement.

Keywords: Takayasu's arteritis, percutaneous transluminal angioplasty, abdominal pain.

INTRODUCTION

Takayasu’s arteritis (TA) is an idiopathic chronic inflammatory disease of the connective tissue, sometimes focal, affecting mainly the aorta and its branches. It has universal distribution and a greater incidence among Asians and women up to the fourth decade of life.1 Typical vascular findings include pulse reduction or even absence; difference in blood pressure values between the upper limbs; claudication; systemic arterial hypertension (SAH) hard to control; pain in the area of the affected arteries, in addition to murmurs in the areas of chronic inflammation, or stenosis of large and medium vessels. From the histopathological point of view, TA is characterized by a granulomatous inflammation that leads to atrophy of the tunica media and hypertrophy of the tunica intima. It usually manifests as stenotic lesions of sudden installation. Aneurysms are less often reported. The clinical manifestations are varied and depend on the affected site. The incidence of mesenteric angina is rare.2

Treatment is mainly based on corticosteroids and immunosuppressants, since some observational studies have reported that patients with TA respond to corticosteroids, methotrexate (MTX), azathioprine (AZA), and cyclophosphamide.1 The introduction of biological therapy brought a new perspective to TA treatment, despite the reduced number of patients already treated.

Drug therapy prevents disease progression, but the already established vascular lesions do not respond properly, representing, thus, a challenge to treatment. In this scenario, percutaneous transluminal angioplasty with stenting is a useful therapeutic strategy, despite restenoses.3

CASE REPORT

The patient is a 33-year-old female complaining of malaise, fever, myalgia, severe pulsing holocranial headache resistant to analgesics, SAH hard to control, right lower limb claudication, and severe abdominal pain that worsened after meals. Blood pressure in the right upper limb was 180 ×; 60 mmHg, while, in the left upper limb, it was 100 ×; 60 mmHg. The physical examination was within the normal range except for a systolic murmur heard on the aortic area and territory of the left brachial artery. The following exams showed no significant alterations: amylase; lipase; stool test for parasites; chest radiography; and abdominal ultrasound. Echocardiography evidenced aneurysmal dilation of the ascending aorta. Angiotomography revealed aneurysm of the ascending aorta and stenosis of the following vessels: right common iliac artery, renal arteries, and superior mesenteric artery. Aiming disease control, prednisone at the dose of 1 mg/kg/day was introduced.

Multislice computed tomography showed aneurysm of the ascending aorta, and stenosis of the right common iliac artery and of the renal arteries (Figures 1A and 1B).



Based on the angiotomographic findings and clinical repercussions, percutaneous transluminal angioplasty was performed and stents placed in the following vessels: right common iliac artery, both renal arteries, and superior mesenteric artery. The angiography prior to angioplasty had shown stenosis of the celiac trunk and superior mesenteric artery (Figure 2A), in addition to stenosis of the right common iliac artery. The final angiographic control showed the improvement in vascularization after stent placement (Figure 2B).



DISCUSSION

The angiotomographic finding of stenosis of the superior mesenteric artery in association with persistent abdominal pain supported the interventional approach by use of percutaneous transluminal angioplasty and stenting. Although restenosis has been reported,3 percutaneous revascularization is a consistent alternative, which has a better prognosis when the disease is clinically controlled. Clinical follow-up should be extended over a prolonged period, mainly because of the small number of cases reported.3

Atherosclerosis is the most common cause of mesenteric ischemia;2 thrombophilias and primary vasculitis constitute the less frequent causes.4 Impairment of the superior mesenteric artery in patients with TA represents, per se,a factor of poor prognosis, because its course can be fulminant and refractory to clinical or surgical treatment.2 Dreadful consequences of mesenteric ischemia are mesenteric infarction, sepsis, and death.2,4

Although not frequent, it is worth considering mesenteric angina in all patients with TA complaining of abdominal pain, mainly if that worsens after meals.4 Angiography is a direct imaging technique that allows assessing vessel impairment.5 However, angiotomography is a non-invasive diagnostic alternative. The ideal treatment is corticotherapy at full doses. In the presence of stenosis with marked flow reduction, stenting should be performed, and preferentially during disease inactivity, when the technique is associated with more favorable results.6

Recent studies have highlighted percutaneous angioplasty as an effective and long lasting method to treat stenosis triggered by primary vasculitis7,8 the restenosis index ranges from 20% to 44%.3,7 Such complication, however, can be approached with a new endovascular intervention without significant complications.7 The open revascularization technique is also a therapeutic possibility with good long-term results.8

REFERENCES

  • 1
    Souza AWS, Neves RMS, Oliveira KR, Sato EI. Tratamento da arterite de Takayasu. Rev Bras Reumatol 2006; 46:2-7.
  • 2
    Simon S, Schittko G, Bösenberg H, Holl-Ulrich K, Schwarz-Eywill M. Fulminant course of a Takayasu's arteritis and rare mesenteric arterial manifestation. Zeitschrift für Rheumatologie 2006; 65(6):520-2.
  • 3
    Almeida GT, Barbosa BML, Biatto JFP, Casaroto E, Loures MAAR. Tratamento coadjuvante da arterite de Takayasu através de angioplastia transluminal percutânea com stents: relato de caso e revisão de literatura. Rev Bras Reumatol 2008; 48:118-21.
  • 4
    Cornejo R, Gatica H, Segovia E, Cortés C. Intestinal necrosis as clinical presentation of Takayasu arteritis. Revista Médica do Chile 2002; 130(10):1159-64.
  • 5
    Tumelero RT, Teixeira JCC, Duda NT, Tognon AP, Rossato M.Tratamento percutâneo multivaso da arterite de Takayasu. Arq Bras Cardiol 2006; 87(5):182-8.
  • 6
    Gelape CL, Alvarenga FC, Figueroa CCS, Ribeiro ALP. Tratamento de estenose de tronco de coronária esquerda na arterite de Takayasu. Rev Bras Reumatol 2007; 47:390-3.
  • 7
    Rits Y, Oderich GS, Bower TC, Miller DV, Cooper L, Ricotta JJ 2nd et al. Interventions for mesenteric vasculitis. J Vasc Surg 2010; 51(2):392-400.
  • 8
    Numano F. Differences in clinical presentation and outcome in different countries for Takayasu's arteritis. Curr Opin Rheumatol 1997; 9:12-5.
  • 9
    Lee BB, Laredo J, Neville R, Villavicencio JL. Endovascular management of takayasu arteritis: is it a durable option? Vascular 2009; 17(3):138-46.
  • Treatment of mesenteric angina in patients with Takayasu's arteritis

    Luana Thayse Barros de LimaI; Georges Basile ChristopoulosII; Virgínia Moreira BragaI; Maria Eliza M. NemézioI; Ana Paula M.M. SouzaI; Ana Clara C. RêgoI
  • Publication Dates

    • Publication in this collection
      04 May 2011
    • Date of issue
      Apr 2011

    History

    • Accepted
      24 Jan 2011
    • Received
      28 Jan 2010
    Sociedade Brasileira de Reumatologia Av Brigadeiro Luiz Antonio, 2466 - Cj 93., 01402-000 São Paulo - SP, Tel./Fax: 55 11 3289 7165 - São Paulo - SP - Brazil
    E-mail: sbre@terra.com.br